Cost‐effectiveness analysis on the surveillance for hepatocellular carcinoma in liver cirrhosis patients using contrast‐enhanced ultrasonography

Abstract

Contrast-enhanced ultrasonography surveillance for HCC is a cost-effective strategy for LC patients and gains their longest additional life years, with similar degree of ICER in the US surveillance group. CEUS surveillance using Sonazoid is expected to be used not only in Japan, but also world-wide.